Reply to: "Transitioning FIB-4 score: From fibrosis screening tool to key biomarker for clinical endpoints"

George Cholankeril1, Jennifer R Kramer2, Xian Yu2

  • 1Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA; Hepatology Program, Division of Abdominal Transplantation, Michael E DeBakey Department of General Surgery, Baylor College of Medicine, Houston, Texas, USA.

Journal of Hepatology
|July 22, 2024
PubMed
Abstract

No abstract available in PubMed .